戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 components of the host response to pulmonary Cryptococcus neoformans infection.
2 ha only during the first week of a pulmonary Cryptococcus neoformans infection.
3 tection was investigated in a mouse model of Cryptococcus neoformans infection.
4 ed immunity is required to clear a pulmonary Cryptococcus neoformans infection.
5 onse polarization using a model of pulmonary Cryptococcus neoformans infection.
6  immune mechanisms for controlling pulmonary Cryptococcus neoformans infection.
7 gy and immunity to Plasmodium falciparum and Cryptococcus neoformans infection.
8 pared outcomes of Cryptococcus gattii versus Cryptococcus neoformans infection.
9 lpha is expressed in the lungs by day 6 post Cryptococcus neoformans infection and could play a role
10 e investigated the pathogenesis of pulmonary Cryptococcus neoformans infection and passive Ab efficac
11                The pathogenesis of pulmonary Cryptococcus neoformans infection and the efficacy of pa
12 n is a rational alternative to treatment for Cryptococcus neoformans infections, as these infections
13                                              Cryptococcus neoformans infections cause approximately 1
14         CBA/J mice with low-level persistent Cryptococcus neoformans infection had CD4+ T cells of ef
15 body administration to mice with established Cryptococcus neoformans infection has been reported to p
16 cterium tuberculosis, Toxoplasma gondii, and Cryptococcus neoformans infection, implicating inflammat
17                       Experimental pulmonary Cryptococcus neoformans infection in BALB/c mice is asso
18  nonprotective, respectively, against lethal Cryptococcus neoformans infection in mice.
19                                 Experimental Cryptococcus neoformans infection in normal mice was com
20                                    Pulmonary Cryptococcus neoformans infection in rats results in a d
21 arization of T cells during murine pulmonary Cryptococcus neoformans infection in the secondary lymph
22                    Therapeutic practices for Cryptococcus neoformans infection in transplant recipien
23          Antifungal therapy cannot eradicate Cryptococcus neoformans infections in immunosuppressed p
24   Cryptococcal meningoencephalitis caused by Cryptococcus neoformans infection is the most common cau
25                                    Pulmonary Cryptococcus neoformans infection of C57BL/6 mice is an
26                                    Pulmonary Cryptococcus neoformans infection of C57BL/6 mice is an
27        Using a mouse model of ABPM caused by Cryptococcus neoformans infection of C57BL/6 mice, the g
28 e highly susceptible to intratracheal (i.t.) Cryptococcus neoformans infection relative to BALB/c mic
29 ll immunity is required to clear a pulmonary Cryptococcus neoformans infection (via the recruitment a
30 y of murine IgG1 mAb 2H1 to modify pulmonary Cryptococcus neoformans infection was investigated in in
31 ing the risk of dissemination and outcome of Cryptococcus neoformans infection were assessed in 111 o